Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection

SAN ANTONIO--(BUSINESS WIRE)--Xenex Disinfection Services today announced that Clece, Spain’s leading healthcare provider of cleaning, maintenance, catering and social services, has chosen Xenex Germ-Zapping Robots™ for room disinfection at hospitals in Spain and Portugal. Clece has deployed Xenex robots at the Vall d'Hebron University Hospital in Barcelona, where they will be used to supplement the hospital’s cleaning and disinfection procedures. Clece will also implement Xenex robots at Ramón y Cajal in Madrid.

“Xenex is ideal for use in hospitals worldwide as we have patented protocols for use in multi-bed wards. The robot’s speed enables it to disinfect areas and rooms quickly so it can be used throughout the entire facility, including multi-bed wards, to enhance patient and healthcare worker safety.”

Infections caused by superbugs like Clostridium difficile (C.diff), Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) are a global problem and Xenex is a proven solution to destroy the deadly microorganisms before they can bring harm to patients and healthcare workers. Xenex’s germ fighting robots take cleaning and decontamination to the next level by using pulsed xenon, an environmentally-friendly inert gas, to create full spectrum, high intensity ultraviolet (UV) light that quickly destroys infectious germs. The robot destroys C.diff spores and other microorganisms in less than five minutes, and Xenex has peer reviewed, published outcome studies showing a greater than 50 percent decrease in C.diff, MRSA and multi-drug resistant organism (MDRO) infections when those hospitals used the Xenex robots to disinfect rooms.

“Xenex germ-zapping robots are already in use in nearly 300 hospitals in the United States, with infection rate reductions reported in several medical journals. We have been very diligent about our international expansion and ensuring that we find the right partners who share our passion for patient safety. We congratulate Clece for bringing this technology to Europe and we look forward to global deployment of our robots to stop the suffering caused by hospital acquired infections,” said Mike DelVacchio, Senior Vice President of Sales and Marketing at Xenex. “Xenex is ideal for use in hospitals worldwide as we have patented protocols for use in multi-bed wards. The robot’s speed enables it to disinfect areas and rooms quickly so it can be used throughout the entire facility, including multi-bed wards, to enhance patient and healthcare worker safety.”
The Xenex robot is designed for speed, effectiveness and ease of use, which allows Clece’s cleaning staff to operate the robot without disrupting hospital operations. With a proven five-minute disinfection cycle, the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. Nearly 300 hospitals, Veterans Affairs, DoD, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S. use Xenex robots.

“The Xenex robots will complement our current methods of cleaning and disinfection of surfaces in hospitals. There are many UV disinfection technologies out there, but only Xenex doesn’t contain mercury bulbs and is proven and published in peer reviewed journals to work in the hospital environment and reduce infections. We will use the robots for the terminal room cleaning of patients infected or colonized with multi-drug resistant microorganisms, because those rooms pose the biggest threat to patient safety,” said José Luis Muñoz Garrid, Director de Hospitales de Clece. “Being able to provide hospitals with this proven technology is an example of Clece’s commitment to innovation and excellence in service. The Xenex robots are capable of destroying non-enveloped viruses in just minutes, so they will play a major role in our infectious disease outbreak protocols.”

According to Clece, the main advantages of Xenex’s robot are:

1. Provides a fast, safe and effective method of disinfection.

2. Preserves the health of healthcare workers and hospital employees by providing thorough disinfection of all surfaces.

3. Uniquely designed for ease of use and portability, Clece’s staff can operate the Xenex robot via an intuitive interface without interrupting the normal operation of the hospital. The robot’s quick five-minute disinfection cycles enable them to use it in many rooms per day.

4. Environmentally-friendly disinfection technology that uses no chemicals and does not contain toxic mercury. No safety or disposal issues associated with mercury bulbs.

The Only UV Disinfection Device Proven to Work in the Hospital Environment.

In the last four years there have been 10 peer reviewed studies published confirming the efficacy of the Xenex Germ-Zapping Robot in the healthcare environment, including three studies showing a decrease in C.diff, MRSA and/or MDRO infections in patients when the hospital utilized the Xenex robot for room disinfection. Xenex is the only UV disinfection provider that has hospital customers publishing infection reduction results in peer-reviewed journals, most with greater than 50 percent decreases in their HAI rates.

About Xenex Disinfection Services
Xenex's patented pulsed xenon Full Spectrum UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to eliminate harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. For more information, visit www.xenex.com.

About Clece
Clece is a multi-company leader in providing integrated services to companies. With nearly 70,000 employees and a presence throughout Spain, including 11,000 employees in Catalunya, Clece provides cleaning services, maintenance, energy, logistics, airport and social services and other professional services for all types of institutions and companies across all sectors.

Source: http://www.businesswire.com

April 15th 2015 back

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more